手法を比較

	Nijmegen Questionnaire for Dysfunctional Breathing	慢性呼吸器疾患質問票
分野	呼吸器学	呼吸器学
系統	Process / pipeline	Process / pipeline
提唱年	1994	1987
提唱者	van Beveren and colleagues, Netherlands	Gordon H. Guyatt, McMaster University
種類	Self-report questionnaire	Self-report or interviewer-administered questionnaire
原典	Van Beveren, T. L., Fülöp, M., van Beek, H. G., & Zijlstra, F. J. (1994). Hyperventilation and panic panic attacks in a group of asthma patients. Respiration, 61(5), 282-287.	Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987). A measure of quality of life for clinical trials in chronic lung disease. Thorax, 42(10), 773-778.
別名	Nijmegen, Nijmegen Questionnaire, DBQ	CRQ, Chronic Respiratory Q
関連	5	5
概要	The Nijmegen Questionnaire is a 16-item self-report instrument designed to identify dysfunctional breathing patterns, particularly hyperventilation syndrome, in patients presenting with respiratory or non-respiratory symptoms. Developed by van Beveren and colleagues in the Netherlands in 1994, it provides rapid assessment of symptoms attributable to chronic hyperventilation: dizziness, chest tightness, muscle tension, paresthesias, and anxiety. The Nijmegen Questionnaire is widely used in respiratory physiology clinics, pulmonary rehabilitation programs, and psychosomatic medicine to detect dysfunctional breathing phenotypes that may masquerade as asthma, anxiety disorders, or cardiopulmonary disease.	The CRQ is a 20-item, four-domain questionnaire developed by Guyatt and colleagues at McMaster University in 1987 to measure health-related quality of life specifically in patients with chronic respiratory disease, particularly chronic obstructive pulmonary disease and cystic fibrosis. Uniquely, the CRQ can be administered by interview or self-report, and its four domains (dyspnea, fatigue, emotional function, mastery) directly address the multidimensional burden of chronic respiratory disease. The CRQ has demonstrated exceptional responsiveness to pulmonary rehabilitation and other interventions, making it a preferred outcome measure in respiratory research and clinical practice.